1. Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide
   Paola Papaldo et al, 2003, Journal of Clinical Oncology CrossRef
2. Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design
   Alfredo Berruti et al, 2002, Journal of Clinical Oncology CrossRef